Bios Partners is a venture capital firm that invests in advanced biotechnology companies located in the Central United States and other overlooked markets, focusing on areas that are typically underinvested compared to coastal biotech hubs. The firm's portfolio includes companies developing therapies across areas such as small molecule drugs, cell therapies, gene therapies, medical devices, and artificial intelligence-driven precision medicine.